Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Ahead of print

Issues

Human chorionic gonadotropin in oncology: a matter of tight (bio)marking

Simona Ferraro
  • Corresponding author
  • Department of Laboratory Medicine, UOC Patologia Clinica, Ospedale “Luigi Sacco”, Via GB Grassi 74, 20157 Milano, Italy
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Giacomo Piero Incarbone / Roberta Simona Rossi
  • Department of Laboratory Medicine, UOC Patologia Clinica, Ospedale “Luigi Sacco”, Milano, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Alberto Dolci
  • Department of Laboratory Medicine, UOC Patologia Clinica, Ospedale “Luigi Sacco”, Milano, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mauro Panteghini
  • Department of Laboratory Medicine, UOC Patologia Clinica, Ospedale “Luigi Sacco”, Milano, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-11-12 | DOI: https://doi.org/10.1515/cclm-2019-0629

References

  • 1.

    Clinical and Laboratory Standards Institute (CLSI). Evaluation of detection capability for clinical laboratory measurement procedures, approved guideline – 2nd ed. CLSI document EP17-A2, 2012. https://clsi.org/standards/products/method-evaluation/documents/ep17/. Accessed: 20 June 2019.

  • 2.

    Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, et al. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy. World J Urol 2019;37:1907–16.CrossrefWeb of SciencePubMedGoogle Scholar

  • 3.

    Lempiäinen A, Hotakainen K, Blomqvist C, Alfthan H, Stenman UH. Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma. Clin Chem 2007;53:1560–1.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 4.

    Ferraro S, Panteghini M. A step forward in identifying the right human chorionic gonadotropin assay for testicular cancer. Clin Chem Lab Med 2019. doi: . [Epub ahead of print].CrossrefPubMedGoogle Scholar

  • 5.

    Ferraro S, Trevisiol C, Gion M, Panteghini M. Human chorionic gonadotropin assays for testicular tumors: closing the gap between clinical and laboratory practice. Clin Chem 2018;64:270–8.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 6.

    Korhonen J, Alfthan H, Ylostalo P, Ylöstalo P, Veldhuis J, Stenman UH. Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. Clin Chem 1997;43:2155–63.PubMedGoogle Scholar

  • 7.

    Fabre E, Jira H, Izard V, Ferlicot S, Hammoudi Y, Theodore C, et al. “Burned-out” primary testicular cancer. BJU Int 2004;94:74–8.PubMedCrossrefGoogle Scholar

  • 8.

    Balalaa N, Selman M, Hassen W. Burned-out testicular tumor: a case report. Case Rep Oncol 2011;4:12–5.PubMedCrossrefGoogle Scholar

  • 9.

    Mosillo C, Scagnoli S, Pomati G, Caponnetto S, Mancini ML, Bezzi M, et al. Burned-out testicular cancer: really a different history? Case Rep Oncol 2017;10:846–50.Web of SciencePubMedGoogle Scholar

  • 10.

    Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH. Expression of human chorionic gonadotropin in testicular germ cell tumors. Urol Oncol 2014;32:727–34.CrossrefWeb of SciencePubMedGoogle Scholar

  • 11.

    Handwerger S, Wilson SP, Tyrey L, Conn PM. Biochemical evidence that human placental lactogen and human chorionic gonadotropin are not stored in cytoplasmic secretion granules. Biol Reprod 1987;37:28–32.PubMedCrossrefGoogle Scholar

  • 12.

    Cathomas R, Klingbiel D, Bernard BD, Lorch A, del Muro XG, Morelli F, et al. FDG PET scan (PET) positive residual lesions after chemotherapy (chemo) for metastatic seminoma: results of an International Global Germ Cell Cancer Group (G3) registry. J Clin Oncol 2017;35(Suppl):4521.Web of ScienceCrossrefGoogle Scholar

About the article

Received: 2019-06-21

Accepted: 2019-10-14

Published Online: 2019-11-12


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), 20190629, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0629.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in